Open AccessIs Ritonavir-boosted Protease Inhibitors (PIs/r) monotherapy noninferior to classic combined antiretroviral therapy (cART)?
Author(s) -
Tomasz Mikuła,
Magdalena Dąbrowska,
Alicja WiercińskaDrapało
Publication year - 2010
Publication title -
hiv and aids review
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.156
H-Index - 8
eISSN - 1732-2707
pISSN - 1730-1270
DOI - 10.1016/s1730-1270(10)60097-5
Subject(s) - cart , ritonavir , medicine , regimen , protease inhibitor (pharmacology) , lipodystrophy , pharmacology , adverse effect , antiretroviral therapy , viral load , combination therapy , human immunodeficiency virus (hiv) , oncology , virology , mechanical engineering , engineering